This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Catamaran Receives 2013 PQA Quality Award For Excellence In Medication Safety

Catamaran Achieves Five-Star Medication Safety Ratings, Drives Improved Health Outcomes

LISLE, IL, May 30, 2013 /PRNewswire/ - Catamaran Corp. (NASDAQ: CTRX, TSX: CCT), a leading provider of pharmacy benefit management (PBM) services and technology, today announced it has received a 2013 PQA Quality Award recognizing its five-star rating on all PQA measures in the Part D Star Ratings program.

The award is administered by Pharmacy Quality Alliance (PQA), an organization dedicated to improving patient health by championing clear performance measures for medication management, and recognizes those organizations that foster exceptional pharmacy quality.

"We are honored to be recognized by PQA for our commitment to continuously enhancing the quality of care in the Medicare arena," said Mark Thierer, Chairman and Chief Executive Officer of Catamaran. "By leveraging our resources, skill, and scale, Catamaran has achieved powerful results in improving health outcomes and reducing costs, all with a laser-sharp focus on patient safety."

PQA's recognition program for prescription drug plans recognizes Medicare prescription drug plans (both MA-PD and PDP) that have demonstrated outstanding performance in medication-related quality as determined through the use of publicly-available performance data for Medicare Part D.

"Catamaran Corporation has achieved industry-leading safety scores in the care of its Medicare members, meeting PQA's standards of excellence for this year's Quality Recognition Award," said Laura Cranston, PQA's Executive Director. "Catamaran serves as a model for the high outcomes that are possible when innovation and commitment come together across an organization."

The award was formally presented at PQA's annual meeting and luncheon on May 29, 2013. This is the third year the consensus-based, multi-stakeholder organization provided this unique recognition to top healthcare providers administrating Medicare prescription services across the nation.

There are five PQA-endorsed quality measures that are used within the CMS' Medicare Star Ratings program.  Details on these measures are available at the PQA website:  www.PQAalliance.org

About Catamaran: Catamaran, the industry's fastest-growing pharmacy benefits manager, helps organizations and the communities they serve take control of prescription drug costs. Managing more than 250 million prescriptions each year on behalf of 25 million members, our flexible, holistic solutions improve patient care and empower individuals to take charge of their health. Processing one in every five prescription claims in the U.S., Catamaran's skill and scale deliver compelling financial results and sustainable improvement in the overall health of members. Catamaran is headquartered in Lisle, Ill. with multiple locations in the U.S. and Canada. For more information, please visit www.catamaranRx.com.

About PQA: Established in 2006, PQA represents pharmacy providers, pharmacy benefit managers, health plans, academicians, consumer advocates, employers, pharmaceutical research and manufacturing companies, and other stakeholders interested in improving the quality of the medication-use system. PQA's mission is to: Improve the quality of medication management and use across health care settings with the goal of improving patients' health through a collaborative process to develop and implement performance measures and recognize examples of exceptional pharmacy quality. PQA provides a leadership role in identification and selection of metrics for evaluation of the quality of the medication-use system, provides education on quality improvement, and connects pharmacists to healthcare improvement initiatives.

SOURCE Catamaran

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs